Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 01 Dec 2025, 05:56 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis focuses on NVIDIA's financial health, highlighting a significant 32% quarter-over-quarter increase in inventory, coupled with a 63% sequential rise in supply commitments. This is attributed to increasing sales and a build-up of inventory to meet customer demand. The speaker re-evaluated NVIDIA's fair value to $214 from a previous $201, an increase of $13, following the earnings release. This adjustment was driven by increased free cash flow expectations for fiscal year 2027. The Nike example is used to illustrate a potential pitfall where mismanaged and over-calculated inventory, leading to decreasing demand, necessitates promotions and discounts.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
